PATENT CLAIM ANALYSIS

Application Number: 15780051
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "182000"]

Abstract:
The present invention relates to a pharmaceutical composition for radioprotection or radiomitigation with respect to radiation-induced damage, the composition comprising a compound of Formula 1, or a pharmaceutically acceptable salt thereof or a solvate thereof.

Claim (Index 10):
The method of  claim 9 , wherein the compound of Formula 1 is 2-methoxyestradiol where R 1  is.

Metadata:
- Claim Count in Document: 40.0
- Percentile: 93.0
- Lexical Diversity: 1.31034
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15852977', '11958353', '12287664', '13813923', '13084408']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7592044694226192
- 35 USC 102 Novelty (BERT): 0.51404863347822
- Combined Prediction Score: 0.7346888858281794
- Mean Citation Score: 195.415314
- Max Citation Score: 204.52432
- Similarity Product: 109.49959698244096

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test